Antibody Discovery for ADC Development
Leveraging advanced platforms to identify and optimize antibodies with high specificity and internalization properties crucial for ADC efficacy.
Our partners and collaborators
We offer a seamless, integrated workflow covering every critical stage of ADC development, ensuring consistency and quality from concept to preclinical stages.
Leveraging advanced platforms to identify and optimize antibodies with high specificity and internalization properties crucial for ADC efficacy.
Tailored synthesis of proprietary linkers and potent payloads, designed for optimal stability, release kinetics, and therapeutic index.
Expertise in various conjugation strategies (e.g., site-specific) to ensure homogeneous and stable ADC constructs.
Comprehensive in vitro characterization, including binding affinity, internalization, cytotoxicity, and stability studies.
Preclinical in vivo efficacy, pharmacokinetics (PK), pharmacodynamics (PD), and toxicology studies using relevant animal models.
Scalable and cGMP-compliant manufacturing services for clinical and commercial supply, ensuring product quality and regulatory adherence.
Our unique strengths empower us to accelerate your research and deliver exceptional results.
We offer a complete process from antibody discovery to manufacturing, simplifying your R&D workflow.
Backed by Ph.D.-level scientists with over a decade of industry experience, ensuring high-quality project execution.
Choose customized service modules based on your specific R&D stage and budget requirements.
A wide range of technology platforms for antibody screening, payload selection, and comprehensive evaluations.
Our proprietary and advanced technology platforms enable us to deliver superior ADC development solutions.
Partner with Creative Biolabs to leverage our expertise and accelerate your Antibody-Drug Conjugate development.
Contact Us Today for a Free Consultation!Our service offers a fully integrated solution from antibody discovery to manufacturing, ensuring seamless transitions. We combine cutting-edge platforms and extensive expertise to accelerate your ADC development timeline.
We employ rigorous quality control measures at every step, utilizing advanced analytical techniques for characterization, stability testing, and potency evaluation. Our conjugation strategies are optimized for homogeneity and stability.
Yes, our DrugLnk™ platform specializes in custom linker-payload synthesis. We work closely with clients to design and synthesize novel linkers and payloads tailored to their specific requirements for optimal performance.
We provide comprehensive in vivo services, including efficacy studies in various tumor models, pharmacokinetic (PK) and pharmacodynamic (PD) profiling, and toxicology assessments. These studies are crucial for evaluating the safety and efficacy of your ADC candidates in a living system.
The timeline can vary significantly depending on the project's complexity, the specific services required, and the client's existing data. We work with each client to establish a detailed project plan and timeline, aiming for efficient progression while maintaining the highest scientific standards. Please contact us for a personalized consultation and quote.
For Research Use Only. NOT FOR CLINICAL USE.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.